IAG Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.55K Hold
17
﹤0.01% 387
2025
Q4
$11.5K Hold
17
﹤0.01% 347
2025
Q3
$10.9K Hold
17
﹤0.01% 365
2025
Q2
$9.12K Hold
17
﹤0.01% 351
2025
Q1
$7.14K Hold
17
﹤0.01% 372
2024
Q4
$7.03K Hold
17
﹤0.01% 386
2024
Q3
$8.59K Hold
17
﹤0.01% 361
2024
Q2
$8.28K Hold
17
﹤0.01% 352
2024
Q1
$9.18K Hold
17
﹤0.01% 322
2023
Q4
$9.44K Hold
17
﹤0.01% 310
2023
Q3
$7.43K Hold
17
﹤0.01% 331
2023
Q2
$8.54K Hold
17
﹤0.01% 329
2023
Q1
$8.5K Hold
17
﹤0.01% 330
2022
Q4
$6.93K Sell
17
-19
-53% -$7.38K ﹤0.01% 326
2022
Q3
$12K Buy
36
+19
+112% +$6.98K ﹤0.01% 255
2022
Q2
$6K Hold
17
﹤0.01% 321
2022
Q1
$9K Hold
17
﹤0.01% 308
2021
Q4
$11K Hold
17
﹤0.01% 288
2021
Q3
$11K Hold
17
﹤0.01% 260
2021
Q2
$11K Hold
17
﹤0.01% 250
2021
Q1
$9K Hold
17
﹤0.01% 273
2020
Q4
$9K Hold
17
﹤0.01% 252
2020
Q3
$7K Hold
17
﹤0.01% 259
2020
Q2
$6K Hold
17
﹤0.01% 273
2020
Q1
$5K Hold
17
﹤0.01% 270
2019
Q4
$5K Buy
+17
New +$4.48K ﹤0.01% 307

Other funds holding IDXX

IAG Wealth Partners's IDXX Position: Q1 2026 in Review

IAG Wealth Partners held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 17 shares worth $9.55K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

IAG Wealth Partners first reported a position in IDXX in Q4 2019 and has held it in 26 quarters since. The position peaked at $12K in Q3 2022. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • IAG Wealth Partners held 17 shares of Idexx Laboratories worth $9.55K as of Q1 2026.
  • IAG Wealth Partners left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of IAG Wealth Partners's portfolio in Q1 2026, its #387 holding.
  • IAG Wealth Partners first reported a position in Idexx Laboratories in Q4 2019 and has held it in 26 quarters since.
  • IAG Wealth Partners's Idexx Laboratories position peaked at $12K in Q3 2022.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on IAG Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.